Discover the detailed record of transactions filed by Dayno Jeffrey M., Directeur Médical. Insider active across 1 companies, notably Harmony Biosciences Holdings, Inc.. Aggregated, 12 disclosures have been recorded. The latest transaction was disclosed on 19 October 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Dayno Jeffrey M. is the Chief Medical Officer at Harmony Biosciences Holdings, Inc. In this role, he oversees the company's medical and clinical activities, ensuring innovation and regulatory compliance. His expertise in medicine and pharmaceutical product development is essential for achieving Harmony Biosciences's growth objectives.